Ratings IM Cannabis Corp.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 03:55:50 2024-07-08 pm EDT			5-day change	1st Jan Change
0.51 ^CAD	0.00%		-17.74%	+10.87%

Jul. 05	Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Friday as Investors Await Hints About Potential Rate Cuts	MT
Jul. 05	IM Cannabis Approves 6-for-1 Share Consolidation	MT

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by -98% by 2026.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
IM CANNABIS CORP.	+10.87%	5.01M	-	-
CURALEAF HOLDINGS, INC.	-3.27%	2.9B		C-
TRULIEVE CANNABIS CORP.	+84.53%	1.74B		C
SIMPLY BETTER BRANDS CORP.	+259.09%	50.96M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality